Word

ABMYVO

Status

Dead

Status Code

605

Status Date

Tuesday, September 17, 2024

Serial Number

98264911

Mark Type

4

Filing Date

Friday, November 10, 2023

Published for Opposition

Tuesday, July 23, 2024

Abandoned Date

Monday, September 16, 2024

Trademark Owner History

Reneo Pharmaceuticals, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the treatment and prevention of mitochondrial diseases and disorders; pharmaceutical preparations for the treatment of genetic diseases and disorders; anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of liver and kidney diseases and disorders; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; pharmaceutical preparations for the prevention and treatment of fibrosis

Trademark Events

Nov 14, 2023

New Application Entered

Dec 13, 2023

New Application Office Supplied Data Entered

Jun 20, 2024

Approved For Pub - Principal Register

Jul 3, 2024

Notification Of Notice Of Publication E-Mailed

Jul 23, 2024

Published For Opposition

Jul 23, 2024

Official Gazette Publication Confirmation E-Mailed

Aug 15, 2024

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jun 18, 2024

Assigned To Examiner

Aug 15, 2024

Teas Change Of Correspondence Received

Aug 15, 2024

Attorney/Dom.Rep.Revoked And/Or Appointed

Aug 16, 2024

Extension Of Time To Oppose Received

Sep 16, 2024

Teas Express Abandonment Received

Sep 17, 2024

Abandonment Notice E-Mailed - After Publication

Sep 17, 2024

Abandonment - After Publication